Sarcoma biopsy

Why MRI should come before biopsy

When a soft-tissue sarcoma is suspected, the safest sequence is usually imaging first, then a planned biopsy, followed by definitive treatment.

Why this matters

MRI defines the lesion’s extent, its relationship to muscles, fascia, vessels and nerves, and the areas most likely to yield diagnostic tissue. This information helps the multidisciplinary team select a biopsy path that can later be removed with the tumour if surgery is required.

De-identified MRI of a soft-tissue tumour obtained before biopsy
De-identified MRI before biopsy. No speculative biopsy tract has been added to the image.

The correct sequence

1Appropriate imaging
2Biopsy planning with the treating team
3Definitive treatment after diagnosis and staging

An unplanned incision or removal can alter anatomical planes, contaminate tissue compartments and make subsequent surgery more complex. A core-needle biopsy is often used, but the technique and route depend on the tumour’s location and the planned definitive operation.

Key point: the biopsy is part of the treatment plan, not a separate preliminary procedure.

Related resources

Sarcoma found after unplanned excisionWhat to do nextPathology reviewWhen the first result is uncertainSarcoma hubDiagnosis and treatment planning
Why specialist care matters

The pathway starts before surgery

In sarcoma, biopsy is part of the future operation. In a specialized sarcoma treatment unit, biopsy trajectory is planned together with the definitive surgical approach.

GEIS 2018 reported 3-year overall survival of 82% in reference centers vs 70.4% in local hospitals. NETSARC 2019 found surgery in a reference center independently associated with better overall survival (HR 0.681). These are observational data, not randomized comparisons. GEIS · NETSARC.

Consultation